Korro Bio, Inc.
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | 100.0% | |
| – | – | – | – | – | -63.7% | – | – | – | 50.2% | – | – | – | |
| – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 49.8% | – | – | – | |
| – | – | – | – | – | 746.9% | 774.1% | 1,440.5% | 1,267.9% | 850.2% | – | – | 2,155.5% | |
| – | – | – | – | – | 367.6% | 307.1% | 469.8% | 597.0% | 479.1% | – | – | 1,121.1% | |
| – | – | – | – | – | 1,114.5% | 1,081.2% | 1,963.2% | 1,864.9% | 1,279.1% | – | – | 3,249.3% | |
| – | – | – | – | – | -1,014.5% | -981.2% | -1,863.2% | -1,764.9% | -1,229.3% | – | – | -3,176.6% | |
| – | – | – | – | – | -928.9% | -917.1% | -1,765.0% | -1,657.0% | -3,824.0% | – | – | -4,441.9% | |
| – | – | – | – | – | 4.5% | – | 0.1% | – | 49.2% | – | – | – | |
| – | – | – | – | – | -933.5% | -917.1% | -1,765.1% | -1,657.0% | -3,873.2% | – | – | -4,477.1% | |
| – | – | – | – | – | -959.4% | -933.1% | -1,779.1% | -1,548.8% | -1,179.1% | – | – | -3,019.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.